In this episode of The Genomics Revolution, host Sian Jarvis is joined by Vincent Plagnol, Chief Scientific Officer of Genomics Limited. Together, they delve into the transformative impact of genomics on modern drug development.
Discover how genomics is not only de-risking the process but also significantly reducing costs, allowing for more efficient drug discovery.
Vincent shares insights on the complexities of genetic variations, the role of data in understanding human biology, and how AI is enhancing the ability to interpret vast amounts of genetic information. Tune in for an enlightening discussion on the future of healthcare through the lens of genomics!
For more information, visit Genomics: https://genomics.com/
Chapters:
(00:00) Genomics Revolution explores how genomics is revolutionizing drug development
(01:13) Genomics is a relatively new branch of science exploring human biology
(05:27) Can you paint a picture for me about the complexity of genomics
(14:00) 95% of drug development failures are due to genetic factors
(15:42) Different Pharma have bet on genetics at different parts of their journey
(16:35) How does AI help in tackling complex scientific problems such as drug targeting
(20:50) Vincent believes genomics holds key to the answer to so many diseases